SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-06-008423
Filing Date
2006-02-13
Accepted
2006-02-13 17:04:30
Documents
1
Group Members
CITADEL DERIVATIVES GROUP LLCCITADEL EQUITY FUND LTD.CITADEL INVESTMENT GROUP, L.L.C.CITADEL KENSINGTON GLOBAL STRATEGIES FUND LTD.CITADEL TRADING GROUP L.L.C.CITADEL WELLINGTON LLCKENNETH GRIFFIN

Document Format Files

Seq Description Document Type Size
1 AMENDMENT a06-4579_16sc13ga.htm SC 13G/A 284132
  Complete submission text file 0001104659-06-008423.txt   286298
Mailing Address 131 S. DEARBORN STREET, 32ND FLOOR CHICAGO IL 60603
Business Address 131 S. DEARBORN STREET, 32ND FLOOR CHICAGO IL 60606 3123952100
CITADEL L P (Filed by) CIK: 0001027745 (see all company filings)

IRS No.: 364111741 | State of Incorp.: IL | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 6701 KAISER DRIVE FREMONT CA 94555
Business Address 6701 KAISER DRIVE FREMONT CA 94555 5106086500
ABGENIX INC (Subject) CIK: 0001052837 (see all company filings)

IRS No.: 943248826 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-54901 | Film No.: 06604603
SIC: 2836 Biological Products, (No Diagnostic Substances)